• Science & Technology
• Health & Medicine

News digest – blood cancer immunotherapy, energy drink ban, ‘no-deal’ Brexit plans and our Annual Review

In the news this week: engineered cell therapy given initial ‘no’ for NHS in England and we publish our research highlights in our 2017/18 annual review. In the news this week: engineered cell therapy given initial ‘no’ for NHS in England and we publish our research highlights in our 2017/18 annual review.

1 September 2018

• Health & Medicine

Immunotherapy drug made available for some NHS patients with Hodgkin lymphoma

The immunotherapy drug pembrolizumab (Keytruda) can now be used to treat some patients with Hodgkin lymphoma on the NHS in England. The immunotherapy drug pembrolizumab (Keytruda) can now be used to treat some patients with Hodgkin lymphoma on the NHS in England.

27 July 2018

• Science & Technology
• Health & Medicine

News digest – immunotherapy for childhood cancer, glowing brain surgery, a new health secretary and CRISPR

A dye used in brain tumour surgery will be rolled out more widely and an immunotherapy drug for neuroblastoma has been made available on NHS. A dye used in brain tumour surgery will be rolled out more widely and an immunotherapy drug for neuroblastoma has been made available on NHS.

14 July 2018

• Health & Medicine

Life-extending immunotherapy approved on NHS for children with neuroblastoma

Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life. Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life.

13 July 2018

• Science & Technology
• Health & Medicine

News digest – breast and lung cancer immunotherapy, vaping and ASCO highlights

Top stories this week: A breast cancer immunotherapy first and lung cancer immunotherapy approved for NHS use in England. Top stories this week: A breast cancer immunotherapy first and lung cancer immunotherapy approved for NHS use in England.

9 June 2018

• Health & Medicine

Lung cancer immunotherapy drug approved for England

The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached. The lung cancer immunotherapy drug pembrolizumab has been made widely available on the NHS in England after a price deal was reached.

6 June 2018

• Science & Technology

ASCO 2018 news: 'blood tests', breast cancer chemo, kinder treatments and immunotherapy

The top stories from the 2018 ASCO annual meeting: overexcited coverage of cancer blood tests and how a gene test can tailor breast cancer treatment. The top stories from the 2018 ASCO annual meeting: overexcited coverage of cancer blood tests and how a gene test can tailor breast cancer treatment.

2 June 2018

• Science & Technology
• Health & Medicine

News digest – Tessa Jowell, cancer waiting times, immunotherapy, and how should we talk about cancer?

Tributes were paid this week following the death of Tessa Jowell, and the Government announced increased funding for brain tumour research. Tributes were paid this week following the death of Tessa Jowell, and the Government announced increased funding for brain tumour research.

19 May 2018

• Science & Technology
• Health & Medicine

News digest – tamoxifen, immunotherapy, cancer myths, and… obesity and BMI?

Breast cancer drugs and cancer myths were in the news this week. Find out why in our news digest. Breast cancer drugs and cancer myths were in the news this week. Find out why in our news digest.

28 April 2018

• Science & Technology
• Health & Medicine

News digest - obesity and cancer, bacteria on skin, new immunotherapy targets and… vaping safety?

In the news this week: Bacteria might protect against skin cancer and worrying obesity projections for millennials. In the news this week: Bacteria might protect against skin cancer and worrying obesity projections for millennials.

3 March 2018

• Health & Medicine

Viruses may boost immunotherapy in brain and breast cancer

Infecting tumours with viruses may boost the success of immunotherapy for brain and breast cancers, according to two new studies. Infecting tumours with viruses may boost the success of immunotherapy for brain and breast cancers, according to two new studies.

3 January 2018

• Science & Technology

Gut bacteria may influence response to cancer immunotherapy

The type of bacteria in the gut of patients with advanced melanoma may influence their response to a certain type immunotherapy, according to new research. The type of bacteria in the gut of patients with advanced melanoma may influence their response to a certain type immunotherapy, according to new research.

2 November 2017